CoreWeave, Inc. (CRWV) EBITDA
- 2026-06-30: Basis Reported; EBITDA $1.34B*; Operating income -$49.00M; Depreciation and amortization $1.39B*.
- 2026-03-31: Basis Reported; EBITDA $1B; Operating income (m); Depreciation and amortization (m).
- 2025-12-31: Basis Reported; EBITDA $730.95M; Operating income (m); Depreciation and amortization (m).
- 2025-09-30: Basis Reported; EBITDA $682.31M*; Operating income $51.85M; Depreciation and amortization $630.46M*.
Complete source-backed ebitda history.
- Available history
- 2023-12-31 to 2026-03-31
- Data captured
Historical EBITDA
EBITDA 3 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|
| 2026-06-30 | Reported | $1.34B* | -$49.00M | $1.39B* | $2.58B | 52.19%* | $6.42B* | $679.00M* | $879.00M | $117.00M | (m) | $62.00M |
|---|
| 2026-03-31 | Reported | $1B | (m) | (m) | (m) | 48.27% | $7.70B | $2.98B | $716.00M | $104.00M | (m) | $84.00M |
|---|
| 2025-12-31 | Reported | $730.95M | (m) | (m) | (m) | 46.50% | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2025-09-30 | Reported | $682.31M* | $51.85M | $630.46M* | $1.36B | 50.00%* | $2.39B* | $1.69B* | $368.82M | $93.00M | (m) | -$126.68M |
|---|
| 2025-06-30 | Reported | $579.00M* | $19.00M | $560.00M* | $1.21B | 47.77%* | $2.45B* | -$251.00M* | $313.00M | $80.00M | (m) | $48.00M |
|---|
| 2025-03-31 | Reported | $416M | (m) | (m) | (m) | 42.36% | $1.41B | $61.00M | $262.00M | $70.00M | (m) | $46.00M |
|---|
| 2024-12-31 | Reported | $477.32M | (m) | (m) | (m) | 63.90% | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2024-09-30 | Reported | $371.14M* | $117.12M | $254.02M* | $583.94M | 63.56%* | $1.22B* | $641.22M* | $143.13M | $14.00M | (m) | $41.66M |
|---|
| 2024-06-30 | Reported | $242.18M* | $77.72M | $164.46M* | $395.37M | 61.25%* | $2.25B* | -$117.82M* | $108.84M | $12.00M | (m) | $40.15M |
|---|
| 2024-03-31 | Reported | $96.36M | (m) | (m) | (m) | 51.07% | $1.74B | $2.04B | $59.22M | $9.00M | (m) | $15.40M |
|---|
EBITDA 12 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|
| 2025-12-31 | Reported | $2.41B | (m) | (m) | (m) | 46.93% | $10.31B | $3.06B | $1.45B | $352.00M | (m) | -$48.00M |
|---|
| 2024-12-31 | Reported | $1.19B | (m) | (m) | (m) | 61.98% | $8.70B | $2.75B | $493.00M | $56.00M | (m) | $119.00M |
|---|
| 2023-12-31 | Reported | $89M | (m) | (m) | (m) | 38.86% | $2.94B | $1.83B | $69.00M | $21.00M | (m) | $36.00M |
|---|